Regeneron Pharmaceuticals (NQ: REGN )
973.80
+5.80
(+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals
Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC
June 17, 2021
Via Benzinga
Exposures
COVID-19
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|